Last reviewed · How we verify
tripotassium dicitrate bismuthate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
tripotassium dicitrate bismuthate (tripotassium dicitrate bismuthate) — Seoul National University Bundang Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| tripotassium dicitrate bismuthate TARGET | tripotassium dicitrate bismuthate | Seoul National University Bundang Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- tripotassium dicitrate bismuthate CI watch — RSS
- tripotassium dicitrate bismuthate CI watch — Atom
- tripotassium dicitrate bismuthate CI watch — JSON
- tripotassium dicitrate bismuthate alone — RSS
Cite this brief
Drug Landscape (2026). tripotassium dicitrate bismuthate — Competitive Intelligence Brief. https://druglandscape.com/ci/tripotassium-dicitrate-bismuthate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab